Xenetic Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $-12.7M | $-12.7M | $57.7K | $1.5M |
| FY2015 | $-5.3M | $-5.3M | $1.7K | $2.2M |
| FY2016 | $-8.8M | $-8.8M | $16.8K | $1.9M |
| FY2017 | $1.5M | $1.5M | $9.3K | $1.8M |
| FY2018 | $-6.5M | $-6.5M | $0 | $1.4M |
| FY2019 | $-6.4M | $-6.4M | — | $806.1K |
| FY2020 | $-4.3M | $-4.3M | — | $468.9K |
| FY2021 | $-4.7M | $-4.7M | — | $410.4K |
| FY2022 | $-4.6M | $-4.6M | — | $511.5K |
| FY2023 | $-4.1M | $-4.1M | — | $283.1K |
| FY2024 | $-2.8M | $-2.8M | — | $171.8K |
| FY2025 | $-2.3M | $-2.3M | — | $64.8K |